舜禹股份 reported revenue of ¥0.23B for the period ended 2026-06-30, -28.4% year on year. Net income was ¥-0.03B, a -13.6% net margin on a 28.8% gross margin. The largest revenue line is 污水处理 at 59% of the total. Free cash flow for the period was ¥-0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.23B | -28.4% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥-0.04B | — |
| Net income | ¥-0.03B | — |
| Gross margin | 28.8% | Net margin -13.6% |
| Revenue Q/Q | -32.2% | — |
| Segment | Revenue | Share |
|---|---|---|
| 污水处理 | ¥0.14B | 59.0% |
| 二次供水 | ¥0.09B | 40.5% |
| 其他(补充) | ¥0.00B | 0.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.17B | 71.2% |
| R&D | ¥0.01B | 6.2% |
| SG&A | ¥0.05B | 22.8% |
| Tax & other | ¥-0.01B | -3.1% |
| Item | Amount |
|---|---|
| Total assets | ¥3.11B |
| Total liabilities | ¥1.70B |
| Shareholders' equity | ¥1.41B |
| Equity / assets | 45.3% |
| Operating cash flow | ¥0.00B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.01B |
| Cash conversion (OCF / net income) | 258% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万邦医药 ・ 上大股份 ・ 儒竞科技 ・ 国际复材 ・ 多浦乐 ・ 福赛科技 ・ 春光集团 ・ 威马农机 ・ 浙江华远 ・ 星宸科技 ・ 骏鼎达 ・ 宏鑫科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies